1306891009: Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\...
• \Product containing abacavir (medicinal product)\Abacavir-containing product in oral dose form\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Product containing abacavir (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing only abacavir and lamivudine (medicinal product)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Product containing abacavir (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Product containing lamivudine (medicinal product)\Lamivudine-containing product in oral dose form\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Product containing lamivudine (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing only abacavir and lamivudine (medicinal product)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Product containing lamivudine (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing lamivudine (medicinal product)\Lamivudine-containing product in oral dose form\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing lamivudine (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing only abacavir and lamivudine (medicinal product)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing lamivudine (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Product containing nucleoside analog (product)\Product containing abacavir (medicinal product)\Abacavir-containing product in oral dose form\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Product containing nucleoside analog (product)\Product containing abacavir (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing only abacavir and lamivudine (medicinal product)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Product containing nucleoside analog (product)\Product containing abacavir (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Product containing nucleoside analog (product)\Product containing lamivudine (medicinal product)\Lamivudine-containing product in oral dose form\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Product containing nucleoside analog (product)\Product containing lamivudine (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing only abacavir and lamivudine (medicinal product)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Medicinal product categorized by structure\Product containing nucleoside analog (product)\Product containing lamivudine (medicinal product)\Product containing abacavir and lamivudine (medicinal product)\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Product manufactured as oral dose form (product)\Lamivudine-containing product in oral dose form\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)
• \Product manufactured as oral dose form (product)\Abacavir-containing product in oral dose form\Product containing abacavir and lamivudine in oral dose form (medicinal product form)\Abacavir and lamivudine only product in oral dose form\Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5316389016	Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5316390013	Abacavir (as abacavir hydrochloride) 600 mg and lamivudine 300 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start